Bo Cumbo jumps from the top commercial post at Sarepta to the helm of a gene therapy startup with some influential backers, big plans and $107M – Endpoints News https://t.co/pdOPN7L1jm
Sad day for the muscle community with the passing of Prof. David Yaffe from our department @WeizmannScience David (born in 1929) has pioneered culture methods for muscle stem cells including the famous C2 cells.
#LetTheScientistsLead If this was a war and the doctors took over the planning, would that make any damn sense? Medical professionals are merely fodder in Trump’s mismanagement. Let’s stand up and say enough, LetTheScientistsLead!
“Doctor groups are recommending testing and isolation for people who lose their ability to smell and taste, even if they have no other symptoms.” https://t.co/x3W9186weE
MDA National Ambassadors Justin, Tana and Faith tried out the new @Microsoft adaptive xbox controller - a 1st xbox experience for Faith. Justin, a strategic and steady driver in the game, mentioned excitement for the ability to customize the controller so anyone can make it work.
Lindsay Alfano of @nationwidekids reminds us that selection of outcome measures is not “one-size-fits-all” - we must continue to re-evaluate the outcome as treatments emerge & ‘natural history’ is redefined. Great Outcome Measures talk at #MDAConference
In yesterday's session on Gene–Targeting Therapies, Dr Robert Brown at the UMass Med School shared progress of a pilot human clinical trial using a gene-targeting therapy for a common mutation in #ALS. #MDAconference
Kicking off the 2019 MDA Clinical and Scientific Conference with a meeting of the MDA Care Center Director physicians. Great discussion underway with the docs trading learnings from across their centers. @MDAorg
Fantastic kick off to the #MDAConference! Today's MDA Scholars session invited 4 early stage scientists to present their research on neuromuscular diseases -- research made possible with Development Grants from @MDAorg.
So excited to see an innovative collaboration between @AmicusRx and @PennMedicin,e which will explore novel gene therapy approaches for treating rare metabolic diseases including #Pompe, #Fabry, and #CDKL5! #RareCompany [https://t.co/LjptKooPEl]